Security
Becton, Dickinson and Co. · BDX
BDXNYSECommon stockCurrentCIK 10795Updated Oct 4, 2026
BDX price & chart
Loading TradingView…
NYSE:BDX on TradingView ↗In the news
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business USA - English USA - English News provided by Waters Corporation Jan 27, 2026, 09:25 ET Share this article Share to X Share this article Share to X Waters Corporation's Q4 2025 Financial Results Conference C ↗
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 55,325,000,000Source | 57,286,000,000Source | 52,780,000,000Source | 52,934,000,000Source |
| Property, Plant and Equipment, NetUSD | 6,997,000,000Source | 6,821,000,000Source | 6,557,000,000Source | 6,012,000,000Source |
| GoodwillUSD | 26,612,000,000Source | 26,465,000,000Source | 24,522,000,000Source | 24,621,000,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 641,000,000Source | 1,717,000,000Source | 1,416,000,000Source | 1,006,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,994,000,000Source | 3,033,000,000Source | 2,534,000,000Source | 2,191,000,000Source |
| Inventory, NetUSD | 3,894,000,000Source | 3,843,000,000Source | 3,273,000,000Source | 3,224,000,000Source |
| Assets, CurrentUSD | 9,255,000,000Source | 10,468,000,000Source | 8,676,000,000Source | 8,141,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 885,000,000Source | 876,000,000Source | 517,000,000Source | 482,000,000Source |
| Other Assets, NoncurrentUSD | 3,056,000,000Source | 2,615,000,000Source | 2,078,000,000Source | 1,848,000,000Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | 0Source | 2,000,000Source |
| Common Stock, Value, IssuedUSD | 371,000,000Source | 371,000,000Source | 371,000,000Source | 365,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 16,622,000,000Source | 16,139,000,000Source | 15,535,000,000Source | 15,157,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,895,000,000Source | -1,732,000,000Source | -1,548,000,000Source | -1,488,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 25,390,000,000Source | 25,890,000,000Source | 25,796,000,000Source | 25,282,000,000Source |
| Additional Paid in Capital, Common StockUSD | 20,075,000,000Source | 19,893,000,000Source | 19,720,000,000Source | 19,553,000,000Source |
| Liabilities and EquityUSD | 55,325,000,000Source | 57,286,000,000Source | 52,780,000,000Source | 52,934,000,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 8,313,000,000Source | 8,956,000,000Source | 6,641,000,000Source | 7,811,000,000Source |
| Operating Lease, Liability, CurrentUSD | 135,000,000Source | 142,000,000Source | 117,000,000Source | 118,000,000Source |
| Accounts Payable, CurrentUSD | 1,974,000,000Source | 1,896,000,000Source | 1,641,000,000Source | 1,699,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 704,000,000Source | 667,000,000Source | 414,000,000Source | 384,000,000Source |
| Other Liabilities, NoncurrentUSD | 2,933,000,000Source | 3,558,000,000Source | 4,582,000,000Source | 5,052,000,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 3,103,000,000Source | 3,476,000,000Source | 2,604,000,000Source | 2,605,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 17,621,000,000Source | 17,940,000,000Source | 14,738,000,000Source | 13,886,000,000Source |
| Restricted Cash and Investments, CurrentUSD | 210,000,000Source | 139,000,000Source | 65,000,000Source | 153,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 2,462,000,000Source | 2,286,000,000Source | 2,288,000,000Source | 2,229,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 258,000,000Source | 247,000,000Source | 259,000,000Source | 233,000,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 410,000,000Source | -98,000,000Source | 15,000,000Source | 631,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | -474,000,000Source | -211,000,000Source | -622,000,000Source | -129,000,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 0Source | 3,924,000,000Source | 0Source | 2,070,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -818,000,000Source | — | — | — |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 480,000,000Source | 444,000,000Source | 382,000,000Source | 178,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 760,000,000Source | 725,000,000Source | 874,000,000Source | 973,000,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 1,000,000,000Source | 500,000,000Source | 0Source | 500,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -3,617,000,000Source | — | — | — |
| Payments of Ordinary Dividends, Common StockUSD | 1,196,000,000Source | 1,100,000,000Source | 1,114,000,000Source | 1,082,000,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -87,000,000Source | -89,000,000Source | -120,000,000Source | -77,000,000Source |
| Repayments of Long-term DebtUSD | 1,789,000,000Source | 1,142,000,000Source | 2,155,000,000Source | 805,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -1,005,000,000Source | 375,000,000Source | 322,000,000Source | -1,233,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 851,000,000Source | 1,856,000,000Source | 1,481,000,000Source | 1,159,000,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 628,000,000Source | 473,000,000Source | 452,000,000Source | 390,000,000Source |
| Income Taxes Paid, NetUSD | 599,000,000Source | 653,000,000Source | 629,000,000Source | 532,000,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 0Source | 4,000,000Source | 5,000,000Source | -45,000,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 262,000,000Source | 249,000,000Source | 261,000,000Source | 240,000,000Source |
| Amortization of Intangible AssetsUSD | 1,586,000,000Source | 1,468,000,000Source | 1,465,000,000Source | 1,430,000,000Source |
| DepreciationUSD | 728,000,000Source | 676,000,000Source | 696,000,000Source | 672,000,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | -5,000,000Source | 5,000,000Source | -3,000,000Source | -35,000,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | -47,000,000Source | -47,000,000Source | -36,000,000Source | -28,000,000Source |
| Gain (Loss) on Disposition of BusinessUSD | 0Source | 0Source | 268,000,000Source | — |
| GoodwillUSD | 26,612,000,000Source | 26,465,000,000Source | 24,522,000,000Source | 24,621,000,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 1,678,000,000Source | 1,705,000,000Source | 1,530,000,000Source | 1,635,000,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | 0Source | 0Source | -46,000,000Source | 144,000,000Source |
| Income Tax Expense (Benefit)USD | 203,000,000Source | 300,000,000Source | 132,000,000Source | 148,000,000Source |
| Investment Income, InterestUSD | 38,000,000Source | 163,000,000Source | 49,000,000Source | 16,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 1,678,000,000Source | 1,705,000,000Source | 1,484,000,000Source | 1,779,000,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 1,678,000,000Source | 1,705,000,000Source | 1,424,000,000Source | 1,689,000,000Source |
| Other Nonoperating Income (Expense)USD | -123,000,000Source | -28,000,000Source | -46,000,000Source | -117,000,000Source |
| Other Operating Income (Expense), NetUSD | -396,000,000Source | -222,000,000Source | 210,000,000Source | -37,000,000Source |
| Payments to Acquire InvestmentsUSD | — | 421,000,000Source | — | — |
| Proceeds from Issuance of Long-term DebtUSD | 0Source | 4,517,000,000Source | 1,662,000,000Source | 497,000,000Source |
| Restricted Cash and Investments, CurrentUSD | 210,000,000Source | 139,000,000Source | 65,000,000Source | 153,000,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 21,840,000,000Source | 20,178,000,000Source | 19,372,000,000Source | 18,870,000,000Source |
| Cost of RevenueUSD | 11,915,000,000Source | 11,053,000,000Source | 11,202,000,000Source | 10,393,000,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 5,278,000,000Source | 4,857,000,000Source | 4,719,000,000Source | 4,709,000,000Source |
| Operating Income (Loss)USD | 2,579,000,000Source | 2,397,000,000Source | 2,111,000,000Source | 2,282,000,000Source |
| Other Nonoperating Income (Expense)USD | -123,000,000Source | -28,000,000Source | -46,000,000Source | -117,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 1,881,000,000Source | 2,005,000,000Source | 1,662,000,000Source | 1,783,000,000Source |
| Income Tax Expense (Benefit)USD | 203,000,000Source | 300,000,000Source | 132,000,000Source | 148,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 1,678,000,000Source | 1,705,000,000Source | 1,484,000,000Source | 1,779,000,000Source |
| Earnings Per Share, BasicUSD per share | 5.83Source | 5.88Source | 4.97Source | 5.93Source |
| Earnings Per Share, DilutedUSD per share | 5.82Source | 5.86Source | 4.94Source | 5.88Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 287,648,000Source | 289,763,000Source | 286,282,000Source | 285,005,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 288,509,000Source | 291,009,000Source | 288,392,000Source | 287,364,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 1,586,000,000Source | 1,468,000,000Source | 1,465,000,000Source | 1,430,000,000Source |
| Costs and ExpensesUSD | 19,261,000,000Source | 17,780,000,000Source | 17,261,000,000Source | 16,588,000,000Source |
| Current Income Tax Expense (Benefit)USD | 677,000,000Source | 511,000,000Source | 754,000,000Source | 277,000,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | -47,000,000Source | -47,000,000Source | -36,000,000Source | -28,000,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 1,678,000,000Source | 1,705,000,000Source | 1,530,000,000Source | 1,635,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -11,000,000Source | 336,000,000Source | 358,000,000Source | 496,000,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | 5.83Source | 5.88Source | 5.14Source | 5.42Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | 5.82Source | 5.86Source | 5.1Source | 5.38Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | 0Source | 0Source | -46,000,000Source | 144,000,000Source |
| Interest ExpenseUSD | 613,000,000Source | 528,000,000Source | 452,000,000Source | 398,000,000Source |
| Investment Income, InterestUSD | 38,000,000Source | 163,000,000Source | 49,000,000Source | 16,000,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 1,678,000,000Source | 1,705,000,000Source | 1,424,000,000Source | 1,689,000,000Source |
| Other Operating Income (Expense), NetUSD | -396,000,000Source | -222,000,000Source | 210,000,000Source | -37,000,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | 0Source | 0Source | 60,000,000Source | 90,000,000Source |
| Research and Development ExpenseUSD | 1,265,000,000Source | 1,190,000,000Source | 1,237,000,000Source | 1,256,000,000Source |
Filing attachments
ef20074240_ex4-1.htm · 8-K · 2026-05-20
EX-4.1 2 ef20074240_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 BECTON DICKINSON EURO FINANCE S.À R.L. as Issuer BECTON, DICKINSON AND COMPANY as Guarantor AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee SIXTH SUPPLEMENTAL INDENTURE Dated as of May 20, 2026 3.855% Notes due 2033 TABLE OF CONTENTS Page ARTICLE I Section 1.1 Definitions. 2 Section 1.2 Terms of the Notes …
Read attachment ↗ef20074240_ex4-2.htm · 8-K · 2026-05-20
EX-4.2 3 ef20074240_ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE NOMINEE OF THE ENTITY APPOINTED AS COMMON SAFEKEEPER FOR EUROCLEAR BANK SA/NV (“EUROCLEAR”) AND CLEARSTREAM BANKING S.A. (“CLEARSTREAM”). TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, AND NOT IN PART, TO NOMINEES OF THE COMMON SAFEKEEPER OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S N…
Read attachment ↗ef20066348_ex99-1.htm · 8-K · 2026-02-25
EX-99.1 2 ef20066348_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap FRANKLIN LAKES, NJ, February 25, 2026 - BD (Becton, Dickinson and Company) (NYSE: BDX) (the “Company” or “BD”), a leading global medical technology company, today announced the early tender results for its previously announced Tender Offers (as defined below) to purchase for cash certain of its outstanding debt securiti…
Read attachment ↗ef20066348_ex99-2.htm · 8-K · 2026-02-25
EX-99.2 3 ef20066348_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase FRANKLIN LAKES, NJ, February 25, 2026 - BD (Becton, Dickinson and Company) (NYSE: BDX) (the “Company” or “BD”), a leading global medical technology company, today announced the consideration payable in connection with its previously announced Tender Offers (as defined below) to purchase for cash up to $2,000,000,000 aggregate purch…
Read attachment ↗ef20065107_ex99-1.htm · 8-K · 2026-02-10
EX-99.1 2 ef20065107_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities FRANKLIN LAKES, NJ, February 10, 2026 - BD (Becton, Dickinson and Company) (NYSE: BDX) (the “ Company ” or “ BD ”), a leading global medical technology company, today announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in the table below (collectively, the “ Securities ” and each a “ s…
Read attachment ↗d104936dex991.htm · 8-K · 2026-02-09
EX-99.1 7 d104936dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation FRANKLIN LAKES, N.J., Feb. 9, 2026 /PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD’s Biosciences & Diagnostic Solutions business and the combination of the business with Waters Corporation (NYSE: WAT). In connection with the transaction, BD…
Read attachment ↗